California Breaks Century Mark in Funding Clinical Trials for Stem Cell and Gene Therapies
Still has $4 billion more to finance revolutionary research
SOUTH SAN FRANCISCO -- The California stem cell agency quietly marked a milestone last week -- hitting 100 clinical trials, a figure that would have been scoffed at during the earliest years in its history.
The century mark was surpassed when directors of the California Institute for Regenerative Medicine (CIRM), as the agency is formally known, approved five clinical trials last Thursday. The actions boosted the total number of trials funded from 98 to 103. The total funding involved is nearly $900 million.
CIRM is the largest state-funded stem cell/gene therapy enterprise in the nation, and the number of trials is virtually certain to be unsurpassed.
On Thursday at the CIRM directors meeting here, the achievement went unnoticed.
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.